Stock Events

Stock Events

XBiotech

€2.17

0

+€0.03+1.41% Tuesday 06:02

Statistics

Day High

2.17

Day Low

2.17

52W High

2.96

52W Low

1.84

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

Jul 21

€1.78

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4XB.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals competes in the biotechnology field, focusing on immunology and inflammatory diseases, similar to XBiotech's focus on True Human antibody therapies.

Amgen is a biotech firm that develops innovative human therapeutics, including treatments for conditions in areas that XBiotech targets, making them direct competitors.

Gilead Sciences

Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, overlapping with XBiotech's market.

Biogen focuses on neurology and rare diseases but also has a portfolio in immunology, competing with XBiotech in the broader biotech and therapeutic antibodies market.

AbbVie operates in the same biopharmaceutical field as XBiotech, with a strong emphasis on immunology and oncology, areas where XBiotech also aims to innovate.

Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals in various areas, including immunotherapy, where XBiotech is also striving to make advancements.

Pfizer is a large pharmaceutical company with a diverse portfolio, including immunology and oncology, competing with XBiotech in the development of novel treatments.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment Janssen, competes in the same therapeutic areas as XBiotech, including immunology and oncology.

Bristol-Myers Squibb

Bristol-Myers Squibb is focused on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, including areas where XBiotech is active.

Novartis is a global healthcare company that operates in various segments, including innovative medicines in areas like immunology, directly competing with XBiotech's research and development focus.

About

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Show more...

CEO

Mr. John Simard

Employees

85

Country

Canada

ISIN

CA98400H1029

Listings

0 Comments

Share your thoughts

FAQ

What is XBiotech stock price today?▼

The current price of 4XB.MU is €2.17 EUR — it has increased by +1.41% in the past 24 hours. Watch XBiotech stock price performance more closely on the chart.

What is XBiotech stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange XBiotech stocks are traded under the ticker 4XB.MU.

Is XBiotech stock price growing?▼

4XB.MU stock has risen by +0% compared to the previous week, the month change is a +7.18% rise, over the last year XBiotech has showed a -14.76% decrease.

Does XBiotech pay dividends?▼

Yes, 4XB.MU dividends are paid en. The last dividend per share was 1.78 EUR. As of today, Dividend Yield (FWD)% is 0%.

How many employees does XBiotech have?▼

As of May 06, 2026, the company has 85 employees.

In which sector is XBiotech located?▼

XBiotech operates in the Health & Wellness sector.

When did XBiotech complete a stock split?▼

XBiotech has not had any recent stock splits.

Where is XBiotech headquartered?▼

XBiotech is headquartered in Austin, Canada.